Key points are not available for this paper at this time.
In several countries, counterfeit and substandard pharmaceuticals are a severe public health concern. This is a global issue, but it is especially prevalent in African countries, where more than 30% of the pharmaceuticals supplied are counterfeit or substandard. Many reasons contribute to the emergence of this issue, which differ from country to country. Online business, light sanctions for drug infringers, ignorance, and an absence of meaningful collaboration amongst players are all variables involved. The Tanzania Food and Drugs Authority (TFDA), Tanzania Police Force, Weights and Measures Agency Tanzania Fair Competition Commission (FCC), Tanzania Bureau of Standards (TBS) and Tanzania Revenue Authority (TRA) Customs are all involved in the fight against counterfeit drugs in Tanzania. Despite this, more work needs to be done to control the supply of counterfeit and substandard pharmaceuticals, which have major health and economic effects. Based on the public health and economic consequences of these low-quality pharmaceuticals, strong international cooperation is required to address the issue. This includes tighter state licensing oversight of pharmaceutical suppliers. In order to identify these products at various supply chain stages, advanced technologies should be used. Finally, consumers must be educated on how to recognize counterfeit pharmaceuticals and their effects.
Petro Karungamye (Mon,) studied this question.